Here are six quick facts:
1. Eight analysts gave the company a “strong buy” rating.
2. Nine analysts rated HCA a “buy.”
3. HCA received a “neutral” rating from 7 analysts.
4. The company has a 50-day moving average of $67.29, with a 200-day moving average of $73.10.
5. The market cap hit $28.09 billion.
6. HCA has a 52-week low of $43.91, with a 52-week high of $95.49.
More articles on transactions & valuation:
National Spine & Pain Centers opens center in Virginia: 5 notes
What’s new in selling ASC real estate, and ASC strategic partnerships?
SCA short interest falls 2%: 5 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
